The use of natural remedies in psychiatry: A commentary

Harvard Review of Psychiatry

Volumn 6, Issue 5, 1999, Pages 279-283

  Mischoulon, David ^a   Rosenbaum, Jerrold F ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT; CYANOCOBALAMIN; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; INOSITOL; KAVA; MELATONIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHENETHYLAMINE; PRASTERONE; VALERIAN;

ALTERNATIVE MEDICINE; ANXIETY NEUROSIS; CULTURAL ANTHROPOLOGY; DEPRESSION; FOOD AND DRUG ADMINISTRATION; HOMEOPATHY; HUMAN; HYPERICUM PERFORATUM; INSOMNIA; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHIATRY; PSYCHOSIS; REVIEW; SOCIAL ASPECT;

EID: 0032926721     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.3109/10673229909000340     Document Type: Review

References (42)

1. Schulz V, Hänsel R, Tyler VE. Rational phytotherapy: a physicians' guide to herbal medicine. 3rd ed. Berlin: Springer, 1998.
2. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993; 328:246-52.
3. Krippner S. A cross-cultural comparison of four healing models. Altern Ther Health Med 1995;1:21-9.
4. Whitmore SM, Leake NB. Complementary therapies: an adjunct to traditional therapies [Letter]. Nurse Pract 1996;21: 12-3.
5. Fisher P. Wheat and chaff in alternative medicine [Letter]. Lancet 1997;349:1629.
6. Anonymous. Clinical practice guidelines in complementary and alternative medicine: an analysis of opportunities and o-stacles. Arch Fam Med 1997;6:149-54.
7. Jenike MA, ed. Hypericum: a novel antidepressant. J Geriatr Psychiatry Neurol 1994;7(suppl 1):S1-68.
8. Singh YN. Kava: an overview. J Ethnopharmacol 1992;37: 13-45.
9. Houghton PJ. The biological activity of valerian and related plants. J Ethnopharmacol 1988;22:121-42.
10. Maurer K, Ihl R, Dierks T, Frolich L. Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res 1997;31:645-55.
11. Warnecke G. Beeinflussung klimakterischer Beschwerden durch ein Phytotherapeutikum: erfolgreiche Therapie mit Cimicifuga-Monoextrakt. Med Welt 1985;36:871-4.
12. Reuter HD, Böhnert KJ, Schmidt U. Die Therapie des prämenstruellen Syndroms mit Vitex agnus castus: kontrollierte Doppelblindstudie gegen Pyridoxin [Abstract]. Z Phytother Abstractband 1995:7.
13. Sack RL, Hughes RJ, Edgar DM, Lewy AJ. Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms? Sleep 1997;20:908-15.
14. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, et al. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 1997;41:311-8.
15. 12, and homocysteine in major depressive disorder. Am J Psychiatry 1997;154:426-8.
16. Alpert JE, Fava M. Nutrition and depression: the role of folate. Nutr Rev 1997;55:145-9.
17. Sabelli H, Fink P, Fawcett J, Tom C. Sustained antidepressant effect of PEA replacement. J Neuropsychiatry Clin Neurosci 1996;8:168-71.
18. Benjamin J, Agam G, Levine J, Bersudsky Y, Kofman O, Belmaker RH. Inositol treatment in psychiatry. Psychopharmacol Bull 1995;31:167-75.
19. Williams LL, Kiecolt-Glaser JK, Horrocks LA, Hillhouse JT, Glaser R. Quantitative association between altered plasma esterified omega-6 fatty acid proportions and psychological stress. Prostaglandins Leukot Essent Fatty Acids 1992;47: 165-70.
20. Davidson JR, Morrison RM, Shore J, Davidson RT, Bedayn G. Homeopathic treatment of depression and anxiety. Altern Ther Health Med 1997;3:46-9.
21. Peet M, Laugharne JD, Mellor J, Ramchand CN. Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation. Prostaglandins Leukot Essent Fatty Acids 1996;55:71-5.
22. Mendelsohn RS. Confessions of a medical heretic. Chicago: Contemporary, 1979.
23. Mendelsohn RS. How to raise a healthy child in spite of your doctor. New York: Ballantine, 1987.
24. Furnham A, Smith C. Choosing alternative medicine: a comparison of the beliefs of patients visiting a general practitioner and a homeopath. Soc Sci Med 1988;26:685-9.
25. Furnham A, Bhagrath R. A comparison of health beliefs and behaviours of clients of orthodox and complementary medicine. Br J Clin Psychol 1993;32:237-16.
26. Weiner JP, Steinwachs DM, Williamson JW. Nurse practitioner and physician assistant practices in three HMOs: implications for future US health manpower needs. Am J Publ Health 1986;76:507-11.
27. Comas-Díaz L. Culturally relevant issues and treatment implications for Hispanics. In: Koslow DR, Salett EP, eds. Crossing cultures in mental health. Washington, DC: Sietar International, 1989:31-48.
28. Rhi BY, Ha KS, Kim YS, Sasaki Y, Young D, Woon TH, et al. The health care seeking behavior of schizophrenic patients in 6 East Asian areas. Int J Soc Psychiatry 1995;41:190-209.
29. Anonymous. Alternative medicine: expanding medical horizons. Rockville, Maryland: National Institutes of Health Office of Alternative Medicine, 1992.
30. Ernst E. Harmless herbs? A review of the recent literature. Am J Med 1998;104:170-8.
31. Brockmöller J, Reum T, Bauer S, Kerb R, Hübner WD, Roots I. Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 1997;30(suppl 2):94-101.
32. MacGregor FB, Abernethy VE, Dahabra S, Cobden I, Hayes PC. Hepatotoxicity of herbal medicines. BMJ 1989;299: 1156-7.
33. Von der Hude W, Scheutwinkel-Reich M, Braun R. Bacterial mutagenicity of the tranquilizing constituents of Valerianaceae roots. Mutat Res 1986;169:23-7.
34. Braun R, Dittmar W, Machut M, Weickmann S. Valepotriate mit Epoxidstruktur-beachtliche Alkylantien. Dtsch Apoth Z 1982;122:1109-13.
35. Norton SA, Ruze P. Kava dermopathy. J Am Acad Dermatol 1994;31:89-97.
36. Duffield PH, Jamieson DD, Duffield AM. Effect of aqueous and lipid-soluble extracts of kava on the conditioned avoidance response in rats. Arch Int Pharmacodyn Ther 1989;301:81-90.
37. Garner LF, Klinger JD. Some visual effects caused by the beverage kava. J Ethnopharmacol 1985;13:307-11.
38. Mathews JD, Riley MD, Fejo L, Muñoz E, Milns NR, Gardner ID, et al. Effects of the heavy usage of kava on physical health: summary of a pilot survey in an aboriginal community. Med J Aust 1988;148:548-55.
39. Vorbach EU, Hübner WD, Arnoldt KH. Effectiveness and tolerance of the Hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients. J Geriatr Psychiatry Neurol 1994;7(suppl 1):S19-23.
40. Harrer G, Hübner WD, Podzuweit H. Effectiveness and tolerance of the Hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study. J Geriatr Psychiatry Neurol 1994;7(suppl 1):S24-28.
41. Anonymous. General information on sponsored research. Rockville, Maryland: National Institutes of Health Office of Alternative Medicine, 1997.
42. Eisenberg DM. Advising patients who seek alternative medical therapies. Ann Intern Med 1997;127:61-9.